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Abstract 
New bioactive 13-epi-neoverrucosane diterpenoid, 5β-acetoxy-13-epi-neoverrucosanic acid (1) along with three known 
secondary metabolites, 13-epi-neoverrucosan-5β-ol (2), chelodane (3) and (E)-β-farnesene (4) were isolated from the MeOH 
extract of east Malaysia’s liverwort Pleurozia subinflata. The chemical structure of new compound was elucidated by the 
analyses of its spectroscopic data (FTIR, NMR and HR-ESI-MS). These epi-neoverrucosane-type compounds seem to be 
notable chemosystematic markers for P. subinflata in Borneo. Compound 3 was widespread in marine sponges however this 
is the first record for 3 to be found in liverwort. These metabolites were tested for their antifungal potentials against selected 
fungi from the marine environment. Compound 1 exhibited effective antifungal activity against Lagenidium thermophilum.
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1 Introduction
Liverworts are the largest group of pioneering land plants 
which arose during the adaptation of plants from marine to 
terrestrial environment [1]. They produced terpenoids and/
or aromatic compounds as their major lipophilic constitu-
ents [2–5]. Many types of sesquiterpenoids from liverworts 
are the enantiomer to those metabolites from higher plants 
[6]. While, diterpenoids such as clerodanes, dolabellanes, 
fusicoccanes, kauranes, labdanes, pimaranes and others were 
found in numerous liverworts [6]. Recently several bioactive 
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cyathane diterpenoids were discovered [7, 8]. Cyathane is 
precursor structure for biosynthesis of the verrucosane-
type diterpenoid, a fused 3,6,6,5-tetracyclic carbon skel-
eton [9]. First verrucosane diterpenoid was isolated from 
Mylia verrucosa [10]. Later, some analogs such as neover-
rucosane-, homoverrucosane-, epi-neoverrucosane- and 
epi-homoverrucosane-type were reported [11–13]. The lat-
est epi-neoverrucosane analog was reported in 2013 [14]. 
Hereby, we report yet another new epi-neoverrucosane dit-
erpenoid, 5β-acetoxy-13-epi-neoverrucosanic acid (1) was 
isolated, along with three known secondary metabolites, 
13-epi-neoverrucosan-5β-ol (2), chelodane (3) and (E)-β-
farnesene (4) from east Malaysia’s liverwort Pleurozia sub-
inflata (Fig. 1).
Besides, liverworts have long been used as traditional 
medicine by the indigenous people in some parts of China. 
In the past half-century, Prof. Yoshinori Asakawa (Tokush-
ima Bunri University, Japan) has begun to study the chemi-
cal composition of liverworts collected from Asia, Europe 
and South America, many of which have reported to have 
diverse chemical structures and exhibited numerous biologi-
cal activities [2, 6]. Thus, research focusing on the biological 
activity of liverwort and industrial use are significant. Our 
research examined the antifungal effects of the four iso-
lated compounds against selected fungi separated marine 
organisms.
2  Results, Discussion and Conclusion
Compound 1 was isolated as colorless oil and analyzed 
for the molecular formula  C22H34O4 by HR-ESI-MS [M 
−  H]− ion at m/z 361.2391. The 13C and 1H NMR data 
(Table 1) indicated the presence of an isopropyl unit at 
δC 31.1, 23.2 and 22.3; δH 1.51–1.55, 1.00 and 0.78, one 
carboxylic carbon at δC 183.0, an acetoxy unit at δC 171.5, 
21.5; δH 2.04, one oxygenated methine at δC 75.1; δH 5.28, 
two tertiary methyls at δC 25.5 and 16.4; δH 1.12 and 0.87, 
six methylenes, four methines, and three quaternary 
carbons which corresponding well to HSQC spectrum. 
Based on these findings, six degrees of unsaturation was 
Fig. 1  Chemical structures of 
1–4 
Table 1  1H and 13C NMR (600 and 150 MHz) data of 1 (in  CDCl3, δ 
in ppm, J in Hz).
No δC δH
1 44.1 2.20 (1H, dd, J = 4.3, 13.1)
2 26.7 0.65 (1H, ddd, J = 4.1, 4.1, 8.3)
3 21.8 0.69 (1H, dd, J = 4.3, 8.3)
0.56 (1H, dd, J = 4.3, 4.3)
4 20.1
5 75.1 5.28 (1H, dd, J = 7.6, 10.7)
6 42.3 1.76 (1H, dd, J = 7.6, 12.5)
0.84 (1H, m)
7 36.8
8 34.9 1.51–1.55 (1H, m)
1.09–1.11 (1H, m)
9 32.3 1.81–1.84 (1H, m)
1.59–1.62 (1H, m)
10 52.0
11 36.3 2.45 (1H, ddd, J = 1.4, 8.9, 11.6)
1.21–1.23 (1H, m)
12 27.5 1.81–1.84 (1H, m)
1.51–1.55 (1H, m)
13 45.3 1.88 (1H, m)
14 51.7 1.67 (1H, dd, J = 7.6, 13.1)
15 31.1 1.51–1.55 (1H, m)
16 22.3 0.78 (3H, d, J = 6.9)
17 23.2 1.00 (3H, d, J = 6.9)
18 25.5 1.12 (3H, s)
19 16.4 0.87 (3H, s)
20 183.0
5-OAc 171.5
21.5 2.04 (3H, s)
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calculated from HR-ESI-MS, and it attributed to two car-
bonyl units and one tetracyclic ring for 1.
The 1H–1H COSY experiment revealed the spin systems 
as depicted by the bold lines in Fig. 2. In the HMBC spec-
trum, the three-bond correlations of  H3–C(16) and  H3–C(17) 
to the opposite carbons C(17) and C(16), and to C(13) and 
C(15), allowed the placement of isopropyl unit at C(13) 
which was further confirmed by 1H–1H COSY. The acetoxy 
unit at C(5) was confirmed by HMBC correlations between 
H–C(5) to 5-OAc. The downfield shifted of 13C and 1H 
NMR at C(5) further supported this deduction. The HMBC 
correlations of  H2–C(11) to C(20); and H–C(14) to C(20) 
suggested the carboxylic carbon at C(10). These findings 
together with HMBC correlations of  H3–C(18) to C(2), C(3), 
C(4) and C(5); and  H3–C(19) to C(1), C(6), C(7) and C(8) 
permitted establishment for the planar structure of 1 (Fig. 2).
The relative stereochemistry of 1 was deduced from the 
NOESY correlations (Fig. 2) and comparison of its chemi-
cal shift, coupling constants and NOE correlations with 
those of known analogs [10–14]. The NOE correlations of 
H–C(5) to  H2–C(6α) (δH 1.76),  H3–C(18) and  H3–C(19); 
and H–C(14) to  H3–C(19) have suggested H–C(5), H–C(14), 
 H3–C(18) and  H3–C(19) on α relative configuration. While, 
NOE correlations of H–C(1) to  H2–C(3β) (δH 0.56) and 
 H2–C(6β) (δH 0.84) showed H–C(1) must be on another 
face, β relative configuration. The earlier NOE cross peak 
of H–C(1) to  H2–C(3) (δH 0.56) has led to the assignment 
of  H2–C(3) (δH 0.56) on β configuration, therefore  H2–C(3) 
(δH 0.69) must be on α configuration. With this finding, the 
configuration at H–C(2) can be assigned based on vicinal 
coupling constants of cyclopropane unit between H–C(2) 
and  H2–C(3α) (3J2-3α = 8.3 Hz) and between H–C(2) and 
 H2–C(3β) (3J2-3β = 4.3 Hz). These coupling constant val-
ues suggested H–C(2) has a cis relationship with  H2–C(3α) 
within the cyclopropane unit, therefore α configuration was 
assigned for H–C(2). While, the carboxyl unit at C(10) was 
assigned on β configuration due to a trans-fused at C/D ring 
junction. Thus, the relative configurations of 1R*, 2S*, 4S*, 
5R*, 7S*, 10S* and 14R* were determined as identical to 
those of known analogs of neoverrucosane and epi-neo-
verrucosane [10–14]. To distinguish epi-neoverrucosane 
from neoverrucosane, the NOE correlations of H–C(1) to 
H–C(15) and  H3–C(17); and H–C(13) to H–C(14), showed 
13-isopropyl unit to H–C(14) has a trans configuration, sug-
gested a epi-neoverrucosane. Furthermore, similar NOE cor-
relations of H–C(1) to H–C(15); and H–C(13) to H–C(14) 
were observed in 12-acetoxy-13-epi-neoverrucosann-5-one 
[14]. On the contrary, these NOE were not observed in 
neoverrucosane-type, neoverrucosan-5β,9β-diol, instead 
H–C(13) to H–C(20) was detected [15]. Thus, the structure 
1 was established without confusion. The configuration of 
isopropyl unit at C(13) generated during formation of tri-
cyclic system (Fig. 3) determined the biosynthesis of neo-
verrucosane or epi-neoverrucosane [9]. To the best of our 
knowledge, compound 1 was considered as first discovery 
of 13-epi-neoverrucosane that containing a carboxyl moiety 
or even among related skeletons such as verrucosane and 
neoverrucosane. The methyl at C(20) of 1 might have fol-
lowed a three-step oxidation, via a hydroxyl and carbonyl, 
to the corresponding carboxylic acid [16], as shown in the 
purposed biosynthetic pathway (Fig. 3).
The known compounds were identified as 13-epi-
neoverrucosan-5β-ol (2) [11], chelodane (3) [17], and (E)- 
β-farnesene (4) [18], after compared its spectroscopic data 
with published literatures. The tetracyclic diterpenes are 
relatively rare in nature, and mainly found in the species of 
Plagiochila, Jamesoniella and Fossombronia [6]. However, 
we found epi-neoverrucosane-type diterpene derivatives (1 
and 2) from east Malaysia’s liverwort, Pleurozia subinflata. 
These secondary metabolites seem to be the good chemos-
ystematic markers for P. subinflata in Borneo. Compound 3 
was widespread in marine sponges such as Chelonaplysilla 
erecta, Raspailia sp. and even in Sigmosceptrella sp. [17, 
19, 20]. However, this is the first record for 3 found in liv-
erwort. Compound 4 was the most common farnesane-type 
sesquiterpene in liverworts. It was distributed throughout 
more than 20 Jungermanniales and Pleuroziales species 
including Pleurozia [6].
Fig. 2  1H–1H COSY, key 
HMBC and NOE correlations 
of 1 
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Compounds 1–4 were evaluated its biological potentials 
against fungal strains isolated from the Bornean ocean, 
Lagenidium thermophilum IPMB 1401, Haliphthoros 
sabahensis IPMB 1402, Fusarium moniliforme NJM 8995, 
Fusarium oxysporum NJM 0179, Fusarium solani NJM 
8996 and Ochroconis humicola NJM 1503 (Table 2). The 
minimum inhibition concentration (MIC) values of com-
pound 1 against L. thermophilum and H. sabahensis were 
12.5 and 50 μg/mL, respectively. While, compounds 2 and 
3 showed MIC values of 100 μg/mL against L. thermophi-
lum. Compound 4 was inactive (> 100 μg/mL) against the 
tested fungi.
In conclusion, this is the first time ever since 2013 of the 
last epi-neoverrucosane being discovered from nature. A 
new 13-epi-neoverrucosane diterpenoid, 5β-acetoxy-13-
epi-neoverrucosanic acid (1) along with three known 
secondary metabolites, 13-epi-neoverrucosan-5β-ol (2), 
chelodane (3) and (E)-β-farnesene (4) were found in east 
Malaysia’s liverwort Pleurozia subinflata. Compound 
1 exhibited effective antifungal activity (MIC values of 
12.5 μg/mL) against Lagenidium thermophilum.
3  Experimental Section
3.1  General Experimental Procedures
Optical rotation was taken on the automatic polarimeter 
(AUTOPOL IV automatic polarimeter) in chloroform solu-
tions at 28 °C. IR spectrum was recorded on the FTIR 
spectroscopy (Perkin Elmer). NMR spectra were recorded 
on the 600 MHz FT-NMR (Jeol) using deuterated chloro-
form  (CDCl3) with tetramethylsilane (TMS) as the inter-
nal standard. MS spectra were obtained using LC-ESI-
IT-TOF-MS (Shimadzu). For preparative TLC, Merck 
Kieselgel 60  F254 was used and Kieselgel 60 was used for 
column chromatography. Purification was performed using 
high performance liquid chromatography (LC-10 AT, Shi-
madzu) equipped with UV detector.
3.2  Biological Materials
Specimens of P. subinflata (M. Suleiman & S.-Y. Ng 5946) 
were collected from Mount Trus Madi (5° 33′ 13.1″ N, 
116° 30′ 41.9″ E), Sabah, Malaysia in August 2015. The 
specimens were identified based on external morphology 
by the fifth author. A voucher specimen (BORHB0026) 
is deposited in the BORNEENSIS Herbarium at Institute 
for Tropical Biology and Conservation (ITBC), Univeristi 
Malaysia Sabah (UMS).
Fig. 3  Proposed biosynthetic pathway of 1 
Table 2  The MIC (μg/mL) of 1–4 against six fungal strains
Positive control: itraconazole MIC 2.0 µg mL−1
Strains MIC (µg/mL)
1 2 3 4
L. thermophilum 12.5 100.0 100.0  > 100.0
H. sabahensis 50.0  > 100.0  > 100.0  > 100.0
F. moniliforme  > 100.0  > 100.0  > 100.0  > 100.0
F. oxysporum  > 100.0  > 100.0  > 100.0  > 100.0
F. solani  > 100.0  > 100.0  > 100.0  > 100.0
O. humicola  > 100.0  > 100.0  > 100.0  > 100.0
55A New Epi-neoverrucosane-type Diterpenoid
1 3
3.3  Extraction and Isolation
The air-dried liverwort specimens (42 g) were extracted 
using 100% methanol (MeOH) (1.0 L × 3 each for two 
days). The crude extract was partitioned between distilled 
water (150 mL) and ethyl acetate (EtOAc) (50 mL × 3). 
After removal of the organic solvent, the EtOAc fraction 
(500 mg) was chromatographed on a Si gel column using 
hexane (Hex) and EtOAc system as eluent with increasing 
polarity (Hex/EtOAc: 9:1, 8:2, 7:3, 5:5, 100% EtOAc) to 
yield five fractions, 1–5. Fraction 2 (76 mg) was subjected to 
repeated preparative TLC with toluene to yield 2 (8.8 mg), 3 
(7.4 mg) and 4 (15.4 mg). Fraction 3 (60 mg) was subjected 
to repeated preparative TLC with hexane/EtOAc: 7:3, and 
the resulted sub-fraction was further purified by semi-pre-
parative high performance liquid chromatography (HPLC) to 
yield 1 (12.8 mg). The isolation was operated using a reverse 
phase  C18 column (5 μm, 10 mm × 250 mm) measured at 
UV wavelength of 210 nm under gradient elution with the 
following conditions: 40–100% acetonitrile (MeCN)/H2O.
3.3.1  5β‑Acetoxy‑13‑Epi‑neoverrucosanic Acid (1)
Colorless oil; [α]D28.0 + 67.8 (c = 0.5,  CHCl3); IR νmax 3488, 
3060, 1735 and 1712 cm−1; 1H NMR  (CDCl3, 600 MHz) δ 
5.28 (1H, dd, J = 7.6, 10.7 Hz, H-5), 2.45 (1H, ddd, J = 1.4, 
8.9, 11.6  Hz, H-11α), 2.20 (1H, dd, J = 4.3, 13.1  Hz, 
H-1), 2.04 (3H, s, OAc), 1.88 (1H, m, H-13), 1.81–1.84 
(1H, m, H-12α), 1.81–1.84 (1H, m, H-9α), 1.76 (1H, dd, 
J = 7.6, 12.5 Hz, H-6α), 1.67 (1H, dd, J = 7.6, 13.1 Hz, 
H-14), 1.59–1.62 (1H, m, H-9β), 1.51–1.55 (1H, m, H-8α), 
1.51–1.55 (1H, m, H-12β), 1.51–1.55 (1H, m, H-15), 
1.21–1.23 (1H, m, H-11β), 1.12 (3H, s, H-18), 1.09–1.11 
(1H, m, H-8β), 1.00 (3H, d, J = 6.9 Hz, H-17), 0.87 (3H, s, 
H-19), 0.84 (1H, m, H-6β), 0.78 (3H, d, J = 6.9 Hz, H-16), 
0.69 (1H, dd, J = 4.3, 8.3 Hz, H-3α), 0.65 (1H, ddd, J = 4.1, 
4.1, 8.3, H-2), 0.56 (1H, dd, J = 4.3, 4.3 Hz, H-3β); 13C 
NMR  (CDCl3, 150 MHz) δ 183.0 (C, C-20), 171.5 (C, OAc), 
75.1 (CH, C-5), 52.0 (C, C-10), 51.7 (CH, C-14), 45.3 (CH, 
C-13), 44.1 (CH, C-1), 42.3  (CH2, C-6), 36.8 (C, C-7), 36.3 
 (CH2, C-11), 34.9  (CH2, C-8), 32.3  (CH2, C-9), 31.1 (CH, 
C-15), 27.5  (CH2, C-12), 26.7 (CH, C-2), 25.5  (CH3, C-18), 
23.2  (CH3, C-17), 22.3  (CH3, C-16), 21.8  (CH2, C-3), 21.5 
 (CH3, OAc), 20.1 (C, C-4), 16.4  (CH3, C-19); negative ion 
HRESIMS: m/z 361.2391 (calcd for  C22H33O4 [M–H]−, 
361.2384).
3.4  Antifungal Assay
The minimum inhibitory concentration (MIC) of the fungi-
static on hyphae was performed by incorporating the pure 
compound solutions (12.5, 25.0, 50.0, 100.0 μg/mL) onto 
PYGS agar in a petri dish followed by inoculation of six 
tested fungal strains [21–23]. The MIC was determined 
visually as the lowest concentration showing no hyphal 
growth after they were incubated at 25 °C for 7 days.
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